Golden Oaks Hospice, Inc. in Chatsworth, California

Golden Oaks Hospice, Inc. is a medicare-certified hospice facility in Chatsworth, California. It is a for profit hospice and this hospice is a Freestanding Hospice. It is located at 21021 Devonshire St Suite 108 in Chatsworth, California. You can reach out to the office of Golden Oaks Hospice, Inc. via phone at (818) 701-7141.

Golden Oaks Hospice, Inc. is first approved in February, 2015 to provide medicare and/or medicaid services and its CMS certification number (CCN) is 751659. San Francisco is the CMS Regional Office responsible for the certification of this hospice.

Contact Information


Golden Oaks Hospice, Inc.
21021 Devonshire St Suite 108, Chatsworth, CA, 91311
(818) 701-7141

News Archive

Alterations in eye movements when reading linked to early indication of Alzheimer's disease

Researchers have suggested that alterations in eye movements when reading could be linked to impairments in working memory and an early indication of Alzheimer's disease according to a new study published in the Journal of Clinical and Experimental Neuropsychology.

The future of cosmetic medicine

With Botox available at the mall and laser-hair removal offered at the neighborhood nail salon how can patients make sure they are getting safe and effective procedures? The future of Cosmetic Medicine will be discussed by leading experts at the Annual Meeting of the American Society for Aesthetic Plastic Surgery (ASAPS) being held at the San Diego Convention Center May 2-6, 2008.

Bioengineers develop synthetic bed to nurture colonies of human embryonic stem cells

The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.

Birmingham Women's Hospital leads the way in genomic diagnosis

Birmingham Women's Hospital (BWH) has adopted a radical new technology to make it easier to identify rare diseases by their genetic causes, leading to a faster and more accurate diagnosis for the patient. The technology being used to do this is called Sapientia™ and it is facilitating the reclassification of disease.

New automated test for gene mutations causing fragile X syndrome

A new automated test could enable population screening to identify carriers of the gene mutations causing fragile X syndrome (FXS), the most common inherited form of mental retardation, reports a study in the April issue of Genetics in Medicine, published by the American College of Medical Genetics and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Read more Medical News

› Verified 7 days ago

Map and Direction



Hospice Profile

NameGolden Oaks Hospice, Inc.
Location21021 Devonshire St Suite 108, Chatsworth, California
Hospice ID751659
CategoryFreestanding Hospice
Ownership TypeProprietary - Corporation
Profit TypeFOR PROFIT
Accreditation ProviderThe Joint Commission (TJC)
SSA county code200

News Archive

Alterations in eye movements when reading linked to early indication of Alzheimer's disease

Researchers have suggested that alterations in eye movements when reading could be linked to impairments in working memory and an early indication of Alzheimer's disease according to a new study published in the Journal of Clinical and Experimental Neuropsychology.

The future of cosmetic medicine

With Botox available at the mall and laser-hair removal offered at the neighborhood nail salon how can patients make sure they are getting safe and effective procedures? The future of Cosmetic Medicine will be discussed by leading experts at the Annual Meeting of the American Society for Aesthetic Plastic Surgery (ASAPS) being held at the San Diego Convention Center May 2-6, 2008.

Bioengineers develop synthetic bed to nurture colonies of human embryonic stem cells

The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.

Birmingham Women's Hospital leads the way in genomic diagnosis

Birmingham Women's Hospital (BWH) has adopted a radical new technology to make it easier to identify rare diseases by their genetic causes, leading to a faster and more accurate diagnosis for the patient. The technology being used to do this is called Sapientia™ and it is facilitating the reclassification of disease.

New automated test for gene mutations causing fragile X syndrome

A new automated test could enable population screening to identify carriers of the gene mutations causing fragile X syndrome (FXS), the most common inherited form of mental retardation, reports a study in the April issue of Genetics in Medicine, published by the American College of Medical Genetics and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Read more Medical News

› Verified 7 days ago

NPI associated with this Hospice

A hospice usually have one NPI number but sometimes it may have multiple NPI numbers. We have found possible NPI number/s associated with Golden Oaks Hospice, Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1538445739
Organization NameGolden Oaks Hospice, Inc.
Address21021 Devonshire St Chatsworth, California, 91311
Phone Number(818)701-7141

News Archive

Alterations in eye movements when reading linked to early indication of Alzheimer's disease

Researchers have suggested that alterations in eye movements when reading could be linked to impairments in working memory and an early indication of Alzheimer's disease according to a new study published in the Journal of Clinical and Experimental Neuropsychology.

The future of cosmetic medicine

With Botox available at the mall and laser-hair removal offered at the neighborhood nail salon how can patients make sure they are getting safe and effective procedures? The future of Cosmetic Medicine will be discussed by leading experts at the Annual Meeting of the American Society for Aesthetic Plastic Surgery (ASAPS) being held at the San Diego Convention Center May 2-6, 2008.

Bioengineers develop synthetic bed to nurture colonies of human embryonic stem cells

The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.

Birmingham Women's Hospital leads the way in genomic diagnosis

Birmingham Women's Hospital (BWH) has adopted a radical new technology to make it easier to identify rare diseases by their genetic causes, leading to a faster and more accurate diagnosis for the patient. The technology being used to do this is called Sapientia™ and it is facilitating the reclassification of disease.

New automated test for gene mutations causing fragile X syndrome

A new automated test could enable population screening to identify carriers of the gene mutations causing fragile X syndrome (FXS), the most common inherited form of mental retardation, reports a study in the April issue of Genetics in Medicine, published by the American College of Medical Genetics and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Read more Medical News

› Verified 7 days ago


Quality of Patient Care at Golden Oaks Hospice, Inc.

Hospice staff should discuss treatment preferences and patient beliefs and values with patients and/or caregivers. They should also identify and provide interventions to address pain, shortness of breath and constipation (caused by opioids) to improve patient comfort and quality of life. Golden Oaks Hospice, Inc. has the following score in these measures of patient care.
Better than National Average Worse than National Average

Quality MeasureProvider ScoreNational Score
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice careNot Available98.3
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice careNot Available93.6
Patients who were checked for pain at the beginning of hospice careNot Available93.9
Patients who got a timely and thorough pain assessment when pain was identified as a problemNot Available77.7
Patients who were checked for shortness of breath at the beginning of hospice careNot Available97.3
Patients who got timely treatment for shortness of breathNot Available94.6
Patients taking opioid pain medication who were offered care for constipationNot Available93.3

News Archive

Alterations in eye movements when reading linked to early indication of Alzheimer's disease

Researchers have suggested that alterations in eye movements when reading could be linked to impairments in working memory and an early indication of Alzheimer's disease according to a new study published in the Journal of Clinical and Experimental Neuropsychology.

The future of cosmetic medicine

With Botox available at the mall and laser-hair removal offered at the neighborhood nail salon how can patients make sure they are getting safe and effective procedures? The future of Cosmetic Medicine will be discussed by leading experts at the Annual Meeting of the American Society for Aesthetic Plastic Surgery (ASAPS) being held at the San Diego Convention Center May 2-6, 2008.

Bioengineers develop synthetic bed to nurture colonies of human embryonic stem cells

The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.

Birmingham Women's Hospital leads the way in genomic diagnosis

Birmingham Women's Hospital (BWH) has adopted a radical new technology to make it easier to identify rare diseases by their genetic causes, leading to a faster and more accurate diagnosis for the patient. The technology being used to do this is called Sapientia™ and it is facilitating the reclassification of disease.

New automated test for gene mutations causing fragile X syndrome

A new automated test could enable population screening to identify carriers of the gene mutations causing fragile X syndrome (FXS), the most common inherited form of mental retardation, reports a study in the April issue of Genetics in Medicine, published by the American College of Medical Genetics and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Read more Medical News

› Verified 7 days ago


Services Provided by Golden Oaks Hospice, Inc.:

Hospice provide various services either through their own staff or through third-party arrangements. Find the list of services provided by Golden Oaks Hospice, Inc. below:
  • By staff
    • Home Health Aide Service
    • Counseling Service
    • Home Maker Service
    • Medical Social Service
    • Nursing Service
    • Physician Service

  • Under Arrangement
    • Medical Supply Service
    • Occupational Therapy
    • Physical Therapy
    • Short Term Inpatient care
    • Speech Pathology
    • Other Services

  • Combination of Staff and Under Arrangement
    • No services

  • Type of Short Term Inpatient Care
    • Respite

Number of Full-time equivalent Employees:

Number of full time equivalent employees at Golden Oaks Hospice, Inc.
Home Health Aides1
Counselors1
Homemakers1
Licensed Practical or Vocational Nurses1
Medical Social Workers 1
Physicians2
Registered Nurses3
Total Employees10

News Archive

Alterations in eye movements when reading linked to early indication of Alzheimer's disease

Researchers have suggested that alterations in eye movements when reading could be linked to impairments in working memory and an early indication of Alzheimer's disease according to a new study published in the Journal of Clinical and Experimental Neuropsychology.

The future of cosmetic medicine

With Botox available at the mall and laser-hair removal offered at the neighborhood nail salon how can patients make sure they are getting safe and effective procedures? The future of Cosmetic Medicine will be discussed by leading experts at the Annual Meeting of the American Society for Aesthetic Plastic Surgery (ASAPS) being held at the San Diego Convention Center May 2-6, 2008.

Bioengineers develop synthetic bed to nurture colonies of human embryonic stem cells

The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.

Birmingham Women's Hospital leads the way in genomic diagnosis

Birmingham Women's Hospital (BWH) has adopted a radical new technology to make it easier to identify rare diseases by their genetic causes, leading to a faster and more accurate diagnosis for the patient. The technology being used to do this is called Sapientia™ and it is facilitating the reclassification of disease.

New automated test for gene mutations causing fragile X syndrome

A new automated test could enable population screening to identify carriers of the gene mutations causing fragile X syndrome (FXS), the most common inherited form of mental retardation, reports a study in the April issue of Genetics in Medicine, published by the American College of Medical Genetics and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Read more Medical News

› Verified 7 days ago


Number of Full-time equivalent Volunteers:

Others2
Total Volunteers2

News Archive

Alterations in eye movements when reading linked to early indication of Alzheimer's disease

Researchers have suggested that alterations in eye movements when reading could be linked to impairments in working memory and an early indication of Alzheimer's disease according to a new study published in the Journal of Clinical and Experimental Neuropsychology.

The future of cosmetic medicine

With Botox available at the mall and laser-hair removal offered at the neighborhood nail salon how can patients make sure they are getting safe and effective procedures? The future of Cosmetic Medicine will be discussed by leading experts at the Annual Meeting of the American Society for Aesthetic Plastic Surgery (ASAPS) being held at the San Diego Convention Center May 2-6, 2008.

Bioengineers develop synthetic bed to nurture colonies of human embryonic stem cells

The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.

Birmingham Women's Hospital leads the way in genomic diagnosis

Birmingham Women's Hospital (BWH) has adopted a radical new technology to make it easier to identify rare diseases by their genetic causes, leading to a faster and more accurate diagnosis for the patient. The technology being used to do this is called Sapientia™ and it is facilitating the reclassification of disease.

New automated test for gene mutations causing fragile X syndrome

A new automated test could enable population screening to identify carriers of the gene mutations causing fragile X syndrome (FXS), the most common inherited form of mental retardation, reports a study in the April issue of Genetics in Medicine, published by the American College of Medical Genetics and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Read more Medical News

› Verified 7 days ago

Certification Details for Golden Oaks Hospice, Inc.:

  • February, 2015 is the initial visit of the health survey for certifications by CMS.
  • It is in compliance at the time of certification survey by CMS.
  • It is in compliance with CMS program requirements based on an acceptable plan for correction of deficiencies.
  • It is eligible to participate in the medicare and/or medicaid program.
  • National Government Services is the Medicare Administrative Contractor (MAC), intermediary or carrier servicing this hospice.
  • Current status is Active Provider.
  • Reason of certification is Initial.
  • End of fiscal year is on 31, December.

Hospices in Chatsworth

Fate Hospice Care, Inc
Location: 20945 Devonshire St, Suite 101b, Chatsworth, California, 91311
Phone: (818) 701-7141
Blue Butterfly Hospice, Inc
Location: 21021 Devonshire Street, Ste 201, Chatsworth, California, 91311
Phone: (818) 701-7141
Golden Oaks Hospice, Inc.
Location: 21021 Devonshire St Suite 108, Chatsworth, California, 91311
Phone: (818) 701-7141
B & D Hospice Services
Location: 21757 Devonshire St, Ste 9, Chatsworth, California, 91311
Phone: (818) 701-7141

Medicare Hospice Care

What is Hospice Care?
Hospice care is a type of care and philosophy of care that focuses on the palliation of a chronically ill, terminally ill or seriously ill patient's pain and symptoms, and attending to their emotional and spiritual needs. Care may be provided in a patient's home or in a designated facility such as nursing home, hospital unit or freestanding hospice, with level of care and sometimes location based upon frequent evaluation of the paients needs. The four primary levels of care provided by hospice are routine home care, continuous care, general inpatient and respite care.

How long can one get medicare hospice care?
Hospice care is for people with a life expectancy of 6 months or less (if the disease runs its normal course). If the person receiving hospice care live longer than 6 months, he or she can still get hospice care.
  • A person can get hospice care for two 90-day benefit periods, followed by an unlimited number of 60-day benefit periods.
  • At the start of each period, the hospice medical director or other hospice doctor must recertify that the person is terminally ill (with a life expectancy of 6 months or less). This step is must for continued hospice care.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.